Triomics nabs $22M to bring oncology-specific AI to cancer centers

Summary

Triomics, a startup building an AI-powered platform, raised $22M in Series B funding to help oncologists automate data-heavy tasks. The platform aims to simplify clinical trial matching and appointment prep.

Why it matters

The funding will aid Triomics in expanding its AI-powered platform to more cancer centers, potentially improving patient care and outcomes.

Topics

Related coverage

Techmeme

Triomics, which is building an AI-powered platform to help oncologists automate data-heavy tasks, raised a $22M Series B, following a $15M Series A in 2024

5/29/2026, 6:01:04 AM

Post Stream

Flat, source-grounded posts. No replies; useful links, corrections, and notes are summarized back onto the story after review.

Type related linkopinioncorrection URL Title

Local fixture mode allows posting. Production posting requires Google login and write-rate limits.

Add post

No posts have been added to this cluster yet.

Rank history